Corticosteroid refractory radiation pneumonitis that remarkably responded to cyclosporin A

Internal Medicine

Volumn 41, Issue 9, 2002, Pages 730-733

  Muraoka, Tomie ^a   Bandoh, Shuji ^a   Fujita, Jiro ^a   Horiike, Atsushi ^a   Ishii, Tomoya ^a   Tojo, Yasunori ^a   Kubo, Akihito ^a   Ishida, Toshihiko ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Immunosuppressive agent; Lung cancer; Steroid therapy; Surfactant protein A; Surfactant protein D

Indexed keywords

CARBOPLATIN; CORTICOSTEROID; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; METHYLPREDNISOLONE; PREDNISOLONE;

AGED; ARTERIAL GAS; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; FEVER; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; MALE; RADIATION PNEUMONIA; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0036745590     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.730     Document Type: Article

References (24)

1. McDonald S, Rubin P, Phillips TL, et al. Injury to the lung from cancer therapy: clinical syndromes, measurable endopionts, and potential scoring systems. Int J Radiat Oncol Biol Phys 31: 1187-1203, 1995.
2. Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med 86: 81-92, 1977.
3. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13: 242-248, 2001.
4. Gentry SE. Interstitial infiltrates in a patient with small cell lung carcinoma. Chest 104: 1887-1888, 1993.
5. McCarty MJ, Lillis P, Vukelja SJ. Azathioprine as a steroid-sparing agent in radiation pneumonitis. Chest 109: 1397-1400, 1996.
6. Takahashi H, Imai Y, Fujishima T, et al. Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis. Eur Respir J 17: 481-487, 2001.
7. Chen Y, Rubin P, Williams J, Hernady E, Smudzin T, Okunieff P. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49: 641-648, 2001.
8. Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 31: 361-369, 1995.
9. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33: 99-109, 1995.
10. Finkelstein IN, Johnston CJ, Baggs R, Rubin P. Early alterations in extra-cellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys 28: 621-631, 1994.
11. Hallman M, Maasilta P, Kivisaari L, Mattson K. Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesothelioma. Am Rev Respir Dis 141: 998-1005, 1990.
12. Rosiello RA, Merrill WW. Radiation-induced lung injury. Clin Chest Med 11: 65-71, 1990.
13. Salinas FV, Winterbauer RH. Radiation pneumonitis: a mimic of infectious pneumonitis. Semin Respir Infect 10: 143-153, 1995.
14. Bayle JY, Nesme P, Bejui-Thivolet F, Loire R, Guerin JC, Cordier JF. Migratory organizing pneumonitis "primed" by radiation therapy. Eur Respir J 8: 322-326, 1995.
15. Fujita J, Bandoh S, Ohtsuki Y, et al. The role of anti-epithelial cell antibodies in the pathogenesis of bilateral radiation pneumonitis caused by unilateral thoracic irradiation. Respir Med 94: 875-880, 2000.
16. Gibson PG, Bryant DH, Morgan GW, et al. Radiation-induced lung injury: a hypersensitivity pneumonitis? Ann Intern Med 109: 288-291, 1988.
17. Murashima A, Sekigawa I, et al. Cyclosporine treatment of advanced interstitial pneumonitis associated with systemic sclerosis. Jpn J Rheum 9: 95-99, 1999.
18. Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol 14: 1045-1047, 1987.
19. Weinblatt ME, Coblyn JS, Fraser PA, et al. Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum 30: 11-17, 1987.
20. Starzl TE, Klintmalm GB, Weil R, et al. Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet 153: 486-494, 1981.
21. Moolman JA, Bardin PG, Rossouw DJ, Joubert JR. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax 46: 592-595, 1991.
22. Shevach EM. The effects of cyclosporin A on the immune system. Ann Rev Immunol 3: 397-423, 1985.
23. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporin induces cancer progression by a cell-autonomous mechanism. Nature 397: 530-534, 1999.
24. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 55: 742-747, 1993.